By Sean Whooley
Boston
Founded: 2017
Machine learning to detect signs of colon cancer
Iterative Scopes develops technology using computer vision and machine learning to provide real-time, computer-aided detection of lesions and other signs of colon cancer.
In January, the company announced that it closed a $5.2 million seed round of financing, bringing its total funds raised to over $7 million at the time. –SW
Investors include: P5 Health Ventures, TAU Ventures, TMC Innovation, Wavemaker Partne
Kommentarer